Role of Interleukin 18 and other inflammatory markers on type 2 diabetic patients on oral hypoglycemic drugs / Taha Abdelaziz Mahdy ; Supervised Abdelgawad A. Fahmi , Mohamed Ali Eldesouky , M. Salah Showman
Material type:
- دور ا{uئإئآ}{uئإإ٧}{uئإ٩٨}{uئإءإ}{uئإؤئ}{uئإإإ}{uئإؤآ}{uئإئ٤}{uئإإ٦}18 و د{uئإئآ}{uئإئآ}ت ا{uئإئآ}{uئإؤئ}{uئإ٩٨}{uئإإأ}{uئإ٨إ}ب ا{uئإئآ}{uئإء٧}{uئإءإ}ى {uئإأآ}{uئإإ٠}{uئإئ٠} {uئإإ٣}{uئإءإ}{uئإآئ}{uئإئ٠} ا{uئإؤئ}{uئإآ٤}{uئإؤأ}{uئإءإ} ا{uئإؤئ}{uئإإ٨}{uئإإإ}ع ا{uئإؤئ}{uئإ٩أ}{uئإ٨إ}{uئإإ٧}{uئإئ٠} {uئإإ٣}{uئإ٩٨}{uئإأأ}{uئإ٨إ}{uئإأ٣}{uئإئ٠} ادو{uئإئ٣}{uئإ٩٤} {uئإء٧}{uئإ٨إ}{uئإؤ٣}{uئإأ٠}{uئإ٩٤} {uئإؤئ}{uئإإ٠}{uئإآ٤}{uئإؤأ}{uئإءإ}{uئإأآ}{uئإإ٦} {uئإأ٣}{uئإءإ}{uئإئ٣}{uئإؤ٦} ا{uئإؤئ}{uئإؤ٤}{uئإإ٢} [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.12.02.M.Sc.2015.Ta.R (Browse shelf(Opens below)) | Not for loan | 01010110067486000 | ||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.12.02.M.Sc.2015.Ta.R (Browse shelf(Opens below)) | 67486.CD | Not for loan | 01020110067486000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
Thesis (M.Sc.) - Cairo University - Faculty of Science - Department of Biochemistry
The pathophysiology of type 2 diabetes involves pro - inflammatory pathways. We determined whether elevated levels of the inflammatory markers interleukin IL - 18and C - reactive protein (CRP) are associated with development of type 2 diabetes mellitus among healthy middle - aged men and women without prior clinical cardiovascular disease or renal disease or hepatic disease. All patients admitted to National Institute of diabetes and endocrinology, Cairo, Egypt. Our population study is consisted of 80 persons were classified into three groups: control group (GI) consisted of 20 clinically healthy adult (10 males and 10 females), Controlled diabetes type 2 (GII) consisted of 34 patients (18 males and 16 females) and uncontrolled diabetes type 2 (GII) consisted of 26 patients (12 males and 14 females). Higher IL - 18 levels were significantly associated with increased risk of developing diabetes (assessed by HbA1c) in diabetic patients compared with healthy subjects at p < 0.001 independent of other inflammatory markers such as CRP. Conclusions/interpretation elevated IL - 18 levels, is associated with an increased risk of future diabetes, and can predict the development of type 2 diabetes mellitus T2DM
Issued also as CD
There are no comments on this title.